Quarterly Accounts Receivable
N/A
30 September 2024
Summary:
Tekla Life Sciences Investors quarterly accounts receivable is not available.HQL Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HQL Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
HQL Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Tekla Life Sciences Investors Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $3.10 M(+2057.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $143.67 K |
FAQ
- What is the all time high quarterly accounts receivable for Tekla Life Sciences Investors?
What is the all time high quarterly accounts receivable for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high quarterly accounts receivable is $3.10 M